Literature DB >> 21851824

Where are the new drugs to treat heart failure? Introduction to the special issue on "key signaling molecules in hypertrophy and heart failure".

Paul C Simpson.   

Abstract

Entities:  

Mesh:

Year:  2011        PMID: 21851824     DOI: 10.1016/j.yjmcc.2011.08.005

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


× No keyword cloud information.
  5 in total

1.  Transcriptome profiling reveals novel BMI- and sex-specific gene expression signatures for human cardiac hypertrophy.

Authors:  Mackenzie S Newman; Tina Nguyen; Michael J Watson; Robert W Hull; Han-Gang Yu
Journal:  Physiol Genomics       Date:  2017-05-12       Impact factor: 3.107

Review 2.  Leveraging Signaling Pathways to Treat Heart Failure With Reduced Ejection Fraction.

Authors:  Miguel Pinilla-Vera; Virginia S Hahn; David A Kass
Journal:  Circ Res       Date:  2019-05-24       Impact factor: 17.367

Review 3.  Cardiac alpha1-adrenergic receptors: novel aspects of expression, signaling mechanisms, physiologic function, and clinical importance.

Authors:  Timothy D O'Connell; Brian C Jensen; Anthony J Baker; Paul C Simpson
Journal:  Pharmacol Rev       Date:  2013-12-24       Impact factor: 25.468

4.  Isoproterenol acts as a biased agonist of the alpha-1A-adrenoceptor that selectively activates the MAPK/ERK pathway.

Authors:  Alicja J Copik; Aleksander Baldys; Khanh Nguyen; Sunil Sahdeo; Hoangdung Ho; Alan Kosaka; Paul J Dietrich; Bill Fitch; John R Raymond; Anthony P D W Ford; Donald Button; Marcos E Milla
Journal:  PLoS One       Date:  2015-01-21       Impact factor: 3.240

5.  A Myocardial Slice Culture Model Reveals Alpha-1A-Adrenergic Receptor Signaling in the Human Heart.

Authors:  R Croft Thomas; Abhishek Singh; Patrick Cowley; Bat-Erdene Myagmar; Megan D Montgomery; Philip M Swigart; Teresa De Marco; Anthony J Baker; Paul C Simpson
Journal:  JACC Basic Transl Sci       Date:  2016-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.